New I-O Targets Herald a Decade of Drugging the Undruggable (Jan 16)
New I-O Targets Herald a Decade of Drugging the UndruggablePublished: Jan 16, 2023 By Heather McKenzieCompugen President and CEO Anat Cohen-Dayag, Ph.D./courtesy of CompugenThere’s a revolution unfolding in cancer therapeutics as…
Novel Alliance Responds to Big Pharma’s Most Pressing AI/ML Needs (Feb 8)
Published: Feb 08, 2023 By Heather McKenzieYair Benita, Ph.D., chief technology officer, AION Labs/courtesy of Tsipi HaitovskyArtificial intelligence and machine learning applications are not the future of drug development; they’re already…
Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions (Feb 17)
Surgical robotics is dominated by various versions of the da Vinci system from Intuitive Surgical, a competent but expensive tool that’s become a standard in modern advanced hospitals. It took…
AI/ML Enables Earlier Cancer Detection, Guided Treatment Feb 22)
Ofer Sharon, M.D., CEO, OncoHost/company courtesy Artificial intelligence and machine learning could change the face of cancer diagnostics.Today, physicians may run blood tests to find biomarkers specific to cancer, conduct imaging…
Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation (March 2)
Radiation is commonly employed in hospitals around the world to treat tumors, typically using gamma ray beams of high energy photons, with a relatively long range, that penetrate all the…
Imagene Profiles Cancer Biomarkers in Real Time (March 22)
Cancer therapies have proliferated over the past few decades, improving outcomes for many patients. But this variety requires accurate diagnostics and appropriate decision making to choose the optimal course of…
6000 Participants from 45 Countries Expected to Participate in the 21st Biomed Israel Conference (April 18)
Israel's leading annual life science conference and exhibition to be held on May 16-18, 2023, at the David InterContinental Hotel in Tel AvivTEL AVIV, ISRAEL, April 18, 2023 /PRNewswire/ -- The…
